Abeona Therapeutics Inc. (ABEO) Two-Stage Excess Return Model - Discounting Cash Flows
Abeona Therapeutics Inc.
ABEO (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Two-Stage Excess Return Model

Used to estimate the value of companies based on two stages of growth. An initial period of high growth, represented by [Sum of discounted excess returns in Growth Stage], followed by a period of stable growth, represented by [Discounted excess return in terminal stage]. Excess Return models are better suited to calculate the intrinsic value of a financial company than an enterprise valuation model (such as the Discounted Free Cash Flow Model).

Read more: GitHub Documentation

Interactive Assumptions

Results

Estimated Value -389,502 Bil. USD
Book value of equity invested 0.832 USD
Sum of discounted excess returns in Growth Stage -23,499 Bil. USD
Terminal stage EPS -37,925 Bil. USD
Terminal stage Book Value 30,028 Bil. USD
Terminal stage Equity Cost 3,285 Bil. USD
Discounted excess return in terminal stage -366,003 Bil. USD
Excess Returns in the Terminal Stage -615,071 Bil. USD
Terminal Cost of Equity (the discount rate) 10.94%
Terminal year's excess return -41,210 Bil. USD
Average historical Return on Equity -126.3%
Average historical Payout Ratio -407,270%
Payout Ratio in stable stage 103.4%
Yield of the U.S. 10 Year Treasury Bond 4.24%

Historical and Forecasted Data

In USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Beginning Book Value 0.693 1.07 1.07 -4414 13622384 -28021676591 28806133228693
Ending Book Value 1.07 0.832 -4414 13622384 -28021676591 28806133228693 30027513277591
EPS -1.55 -0.91 -1.35 5575 -17205071 35391377534 -36382146267840
Return on Equity -429.9% -100.3% -126.3% -126.3% -126.3% -126.3% -126.3%
Dividend per Share
3706 4413 -13621223 28018093904 -28798763527750 -37603526316738
Payout Ratio -325,800% -407,270% -325,800% -244,320% -162,850% -81,370% 103.4%
Retained Earnings
-3707 -4415 13626798 -28035298975 28834154905284 1221380048897
Equity Cost 0.076 0.117 0.117 -482.9 1490288 -3065571419 3151390975219
Cost of Equity 10.94% 10.94% 10.94% 10.94% 10.94% 10.94% 10.94%
Excess Return -1.63 -1.03 -1.47 6057 -18695360 38456948953 -39533537243059
Discounted Excess Return
-1.33 4922 -13692077 25387631131 -23524741864758

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Net Income -50.89 -44.19 -63.73 -54.19 -31.81 -84.94 -84.23 -76.28 -56.67 -27.32 -21.87 -14.53
Total Stockholders Equity 83.76 41.4 44.03 14.83 26.76 42.37 102.6 178.4 134 170.1 99.1 67.72
Return on Equity -126.3% -100.3% -429.9% -202.5% -75.08% -82.82% -47.21% -56.91% -33.32% -27.57% -32.3% -301.6%
Dividends Paid to Common Shareholders 184,491 184,491
Payout Ratio -333,210% -407,270% -325,800% -325,800% -325,800% -325,800% -325,800% -325,800% -325,800% -325,800% -325,800% -325,800%
Shares Outstanding 12.34 49.78 41.05 21.38 7.86 3.94 3.71 2.01 1.9 1.67 1.37 1.1
Earnings per Share -15.16 -0.91 -1.55 -2.53 -4.05 -21.5 -22.75 -38.07 -29.81 -16.4 -16 -13.16
Dividend per Share 3706 3706
Dividend Growth Rate
Book Value 39.96 0.832 1.07 0.693 3.4 10.76 27.66 88.59 70.51 102.2 72.49 61.34
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us